David
Jiménez Castro

2024

1. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

   Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152

2. C-reactive Protein and Risk of Right Ventricular Dysfunction and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

   Archivos de Bronconeumologia, Vol. 60, Núm. 6, pp. 344-349

3. Chronic thromboembolic pulmonary hypertension treatment and sex: Systematic review and meta-analysis

   Medicina Clinica, Vol. 163, Núm. 6, pp. 269-274

4. Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis

   Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537

5. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

   Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246

6. Concordancia entre las escalas de valoración del riesgo de tromboembolismo venoso en pacientes con patología médica en urgencias

   Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 36, Núm. 5, pp. 342-350

7. Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review

   Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 6, pp. 851-865

8. Duration of anticoagulation of venous thromboembolism

   Presse Medicale

9. Enfermedades vasculares del pulmón.

   Medicina interna (Elsevier España), pp. 767-778

10. External validation of the PE-SARD risk score for predicting early bleeding in acute pulmonary embolism in the RIETE Registry

    Thrombosis Research, Vol. 235, pp. 22-31

11. Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications

    Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 5, pp. 773-789

12. High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients with Acute Pulmonary Embolism

    JAMA Cardiology, Vol. 9, Núm. 1, pp. 64-70

13. Impact of a pulmonary embolism response team (PERT) in the prognosis of patients with acute symptomatic pulmonary embolism

    Revista Clinica Espanola, Vol. 224, Núm. 3, pp. 141-149

14. Incidence and predictors of post-thrombotic syndrome in patients with proximal DVT in a real-world setting: findings from the GARFIELD-VTE registry

    Journal of Thrombosis and Thrombolysis, Vol. 57, Núm. 2, pp. 312-321

15. Integration of Extracorporeal Membrane Oxygenation into the Management of High-Risk Pulmonary Embolism: An Overview of Current Evidence

    Hamostaseologie, Vol. 44, Núm. 3, pp. 182-192

16. International Clinical Practice Guideline Recommendations for Acute Pulmonary Embolism: Harmony, Dissonance, and Silence

    Journal of the American College of Cardiology, Vol. 84, Núm. 16, pp. 1561-1577

17. Lung Cancer Related Thrombosis (LCART): Focus on Immune Checkpoint Blockade

    Cancers, Vol. 16, Núm. 2

18. Obesity a Prognostic Marker in Intermediate-high risk Pulmonary Embolism (PE)? RIETE Registry Review

    Thrombosis Update

19. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease

    Nature Reviews Cardiology, Vol. 21, Núm. 8, pp. 574-592

20. Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trial

    Thrombosis Research, Vol. 235, pp. 79-87